Glioma: all 1,425 studies
Page 12 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- Phase I/II Cabazitaxel for Recurrent Malignant GliomaWithdrawnNCT01740570Phase 1/2
- Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving TemozolomideCompletedNCT01729260Phase 1
- Re-irradiation of High Grade Gliomas: a Quality of Life StudyWithdrawnNCT01711580
- Non Invasive IDentification of Gliomas With IDH1 MutationCompletedNCT01703962
- Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).CompletedNCT01688401Phase 1
- A Dose-Escalation Study in Participants With Recurrent Malignant GliomaCompletedNCT01682187Phase 1
- Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II GliomasCompletedNCT01678352Early Phase 1
- Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma PatientsStatus unknownNCT01672463Phase 1
- Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant GliomasStatus unknownNCT01670890Phase 2
- Multimodal MR Imaging in Patients With Glioblastoma Treated With Dendritic Cell TherapyCompletedNCT01657734
- Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant GliomaStatus unknownNCT01656980Phase 3
- Carboplatin in Treating Patients With Recurrent High-Grade GliomasCompletedNCT01644955Phase 1
- Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)CompletedNCT01644773Phase 1
- Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant GliomaCompletedNCT01639612Phase 1
- Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant GliomaStatus unknownNCT01637753Not applicable
- Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in ChildrenCompletedNCT01635140Phase 3
- Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis GliomasCompletedNCT01574092Phase 2
- Study of DC Vaccination Against GlioblastomaStatus unknownNCT01567202Phase 2
- Pilot Immunotherapy Trial for Recurrent Malignant GliomasCompletedNCT01550523Phase 1
- A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade GliomaCompletedNCT01547546Phase 1
- Efficacy Study of Radiotherapy Alone Versus CCRT With Temozolomide in Grade III Gliomas Without 1p/19q CodeletionStatus unknownNCT01534845Phase 2
- Gene Expression, Immunological Status and Metabolome in Glioma PatientsStatus unknownNCT01525459
- Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and AdolescentsTerminatedNCT01517776Phase 2
- MRI-Guided Laser Induced Thermal TherapyTerminatedNCT01515085
- Convection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation TherapyCompletedNCT01502917Phase 1
- Fluorescence-guided Surgery for Low- and High-grade GliomasCompletedNCT01502280Phase 3
- Permeability Map to Distinguish Progression From Pseudoprogression in High-Grade GliomaStatus unknownNCT01499823
- Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent GliomaCompletedNCT01480050Phase 1
- iMRI Guided Resection in Cerebral Glioma SurgeryCompletedNCT01479686Phase 3
- Safety Study of VAL-083 in Patients With Recurrent Malignant GliomaCompletedNCT01478178Phase 1/2
- AMG 595 First-in-Human in Recurrent GliomasCompletedNCT01475006Phase 1
- Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)CompletedNCT01469247Phase 1/2
- Imaging Malignant Glioma With 68Ga-DOTATOC PET/CTCompletedNCT01460706Phase 2/3
- More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided SurgeryWithdrawnNCT01445691Phase 2
- A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent GliomasCompletedNCT01445119Phase 1
- Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone SurgeryCompletedNCT01417507
- Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem GliomaTerminatedNCT01400672Phase 1
- PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade GliomaCompletedNCT01393912Phase 1
- Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant GliomaCompletedNCT01392209Phase 1
- An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.CompletedNCT01386580Phase 1/2
- High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent GliomaTerminatedNCT01378481Phase 1
- Proton Radiation Therapy for GliomasActive, not recruitingNCT01358058Not applicable
- A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain TumorsTerminatedNCT01351519Phase 2
- Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade GliomaTerminatedNCT01339039Phase 1
- Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade GliomasStatus unknownNCT01317888Not applicable
- AZD8055 for Adults With Recurrent GliomasCompletedNCT01316809Phase 1
- Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II GliomaTerminatedNCT01305122Not applicable
- (11C)dLop as a Marker of P-Glycoprotein Function in Patients With GliomasTerminatedNCT01281982
- RO4929097 in Treating Patients With Recurrent Invasive GliomasTerminatedNCT01269411Phase 1
- Image Guided Therapy in the Treatment of GliomasTerminatedNCT01263821Not applicable
- Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway GliomaWithdrawnNCT01260103Phase 3
- EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant GliomasCompletedNCT01257594Phase 1
- Vaccine Therapy and Sargramostim in Treating Patients With Malignant GliomaCompletedNCT01250470Phase 1
- MK-2206 for Recurrent Malignant GliomaWithdrawnNCT01249105Phase 2
- Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for GliomaStatus unknownNCT01235845Phase 1/2
- Yoga Therapy in Treating Patients With Malignant Brain TumorsTerminatedNCT01234805Not applicable
- Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain MetastasesCompletedNCT01234740Phase 1
- Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult GliomasTerminatedNCT01229644Phase 2
- Advanced MR Techniques in Detection of Tumor Infiltration and Grading in GliomasCompletedNCT01225003
- Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine GliomasCompletedNCT01222754Phase 1
- A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant GliomaCompletedNCT01220271Phase 1/2
- Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) StudyCompletedNCT01212731
- Dendritic Cell Vaccine for Patients With Brain TumorsCompletedNCT01204684Phase 2
- HYPONCO - Hypoxia in Brain TumorsCompletedNCT01200134Phase 2
- Radiation Planning Study for High Grade Brain TumorsCompletedNCT01191346
- A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade GliomasCompletedNCT01172964Phase 1
- Study of NPC-07 for Fluorescence-guided Resection of Malignant GliomasCompletedNCT01167322Phase 3
- Carbon Ion Radiotherapy for Recurrent GliomasCompletedNCT01166308Not applicable
- Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant GliomaCompletedNCT01165632Early Phase 1
- Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine GliomaCompletedNCT01165333Phase 1
- Bevacizumab in Recurrent Grade II and III GliomaCompletedNCT01164189Phase 2
- A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant GliomaCompletedNCT01156584Phase 1
- Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain TumorsTerminatedNCT01148966Phase 1
- Nimotuzumab and Radiotherapy in Pediatric Patients With GliomaCompletedNCT01145170Phase 2
- Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant GliomaStatus unknownNCT01144988Phase 2
- Cellular Immunotherapy Study for Brain CancerCompletedNCT01144247Phase 1
- Development of Magnetic Resonance Spectroscopy (MRS) Biomarkers of Tumor Metabolism (MK-0000-145)CompletedNCT01138813
- Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1
- RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaCompletedNCT01119599Phase 1
- A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With GliomasWithdrawnNCT01117155
- Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant GliomasStatus unknownNCT01107522Phase 1
- Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant GliomaTerminatedNCT01103375Phase 1
- FET-PET for Diagnosis and Monitoring in Patients With Low Grade GliomaStatus unknownNCT01089244
- Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 1
- Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2CompletedNCT01082926Phase 1
- Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsCompletedNCT01076530Phase 1
- Hypertension Monitoring in Glioma Patients Treated With BevacizumabTerminatedNCT01046279
- Proton Beam Radiation Therapy in Treating Patients With Low Grade GliomasCompletedNCT01024907Phase 1/2
- A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV GliomaCompletedNCT01020292Phase 1
- Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent GliomaTerminatedNCT01011231Phase 2
- Study of Blood and Cheek Cell Samples From Patients With GliomaCompletedNCT01009307
- Study of Tissue and Blood Samples From Patients With Low-Grade GliomaCompletedNCT01004523
- Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)CompletedNCT00996723Phase 1
- Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaCompletedNCT00994500Phase 1
- Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor PatientsWithdrawnNCT00985036
- Pharmacokinetics (PK) Study of AC480 for Recurrent GliomaCompletedNCT00979173Phase 1
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade GliomaActive, not recruitingNCT00978458Phase 3
- Comparison of Neuro-navigational Systems for Resection-Control of Brain TumorsStatus unknownNCT00977327Not applicable
- A Pilot Study of Using Video Images in Advance Care Planning in Malignant Glioma PatientsCompletedNCT00970788Not applicable
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid TumorsCompletedNCT00967577Phase 1